DPP-4 Inhibition Ameliorates Pancreatic β-Cell Failure and Improves Glucose Tolerance in the Mouse Model of Wolfram Syndrome

Journals Menu

Follow SCIRP

ISSN Print: 2160-5831
ISSN Online: 2160-5858
www.scirp.org/journal/jdm
E-mail: jdm@scirp.org

Citations h5-index & Ranking*

"DPP-4 Inhibition Ameliorates Pancreatic β-Cell Failure and Improves Glucose Tolerance in the Mouse Model of Wolfram Syndrome"
written by Yasuhiro Tanji, Suguru Yamaguchi, Yasushi Ishigaki, Hideki Katagiri, Yoshitomo Oka, Hisamitsu Ishihara,
published by Journal of Diabetes Mellitus, Vol.5 No.2, 2015

has been cited by the following article(s):

[1]	WOLFRAM SYNDROME: FROM POINT MUTATION TO CELL DYSFUNCTION
	2022

[2]	Different clinical entities of the same mutation: a case report of three sisters with Wolfram syndrome and efficacy of dipeptidyl peptidase-4 inhibitor therapy
	2021

[3]	Severe Wolfram Syndrome Caused by a Novel Frameshift Mutation in WFS1 Gene: Effect on the WFS1/CaM Interaction and Phenotype-Genotype Correlation
	Open Journal of …, 2021

[4]	Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy
	2019

[1]	A Pair of Siblings With Wolfram Syndrome: A Review of the Literature and Treatment Options Journal of Investigative Medicine High Impact Case Reports, 2023 DOI:10.1177/23247096221150631

[2]	Different clinical entities of the same mutation: a case report of three sisters with Wolfram syndrome and efficacy of dipeptidyl peptidase-4 inhibitor therapy Journal of Pediatric Endocrinology and Metabolism, 2021 DOI:10.1515/jpem-2020-0699

[3]	Different clinical entities of the same mutation: a case report of three sisters with Wolfram syndrome and efficacy of dipeptidyl peptidase-4 inhibitor therapy Journal of Pediatric Endocrinology and Metabolism, 2021 DOI:10.1515/jpem-2020-0699

Follow SCIRP